Ishaanav

Ishaanav Biotech is a research-driven biotechnology company based in India, focused on the development of high-quality biosimilars and recombinant proteins. The company offers comprehensive Contract Research and Manufacturing Services (CRAMS), specializing in molecular biology, process development, and analytical characterization. Ishaanav's portfolio targets critical therapeutic areas including oncology, autoimmune diseases, and diabetes. They utilize advanced expression platforms such as Pichia pastoris, E. coli, and CHO cell lines to ensure scalable and cost-effective production. By integrating Quality by Design principles, Ishaanav aims to accelerate the path from laboratory research to commercial manufacturing for its global partners. The company provides end-to-end solutions from gene cloning to pilot-scale production, catering to both domestic and international biopharmaceutical markets.